PGS is the evolution of PGD. It involves the screening of eggs or embryos for chromosomal abnormalities. It helps specific groups of infertile patients or those at increased risk of producing embryos with abnormal chromosomes (aneuploid embryos) increase the chances of identifying embryos containing the correct number of chromosomes, thereby improving the pregnancy rate and reducing the risk of miscarriage.
Theoretically, PGS may reduce risk of miscarriage but this has not yet been conclusively proven. PGS can increase IVF pregnancy rates by helping embryologists to identify the embryos most likely to produce a pregnancy, allowing them to be prioritised for transfer to the womb.
PGS can be offered after a discussion with Mr. Shah or Mr. Gudi through the London Women’s Clinic and is at an extra cost to IVF/ICSI.